Price movement over the last 24 hours
Polkadot vs Enzyme — how do they compare? Polkadot trades at Rp15,047 (market cap Rp25,48T, Rp1,24T 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Polkadot is far larger — about 189965× Enzyme's market cap, and Polkadot's supply is capped (1,7B / 2,1B DOT (81%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Polkadot for 116 Days and Enzyme for 28 Days on average.
| DOT | MLN | |
|---|---|---|
Market Cap | Rp25,48T | Rp134,13M |
Volume (24h) | Rp1,24T | Rp104,56M |
Circulating Supply | 1,7B / 2,1B DOT (81%) | 3,3M MLN |
Typical Hold Time | 116 Days | 28 Days |
Signals from Pluang's Aura AI — not financial advice
Polkadot is trading at Rp15,108 with a market cap of Rp25.48T, showing a bearish technical signal driven by moving averages. The current price sits near support at S1 (Rp15,057) with neutral oscillators. No major protocol updates or ecosystem news are available, keeping fundamental developments quiet. The asset's circulating supply is 1.7M DOT (81% of max), with an average hold time of 116 days indicating moderate holder patience amid market volatility.
Overall outlook is cautious due to bearish technicals and lack of recent catalysts. Key opportunities include potential rebounds from support levels if network activity picks up. Major risks involve high volatility, regulatory uncertainty in crypto markets, and low liquidity depth. Investors should monitor on-chain metrics and broader crypto sentiment for directional cues.
Enzyme (MLN) shows a market cap of Rp134,13M with 3.3 million tokens in circulation. The asset demonstrates moderate trading activity with a 28-day average hold time suggesting stable investor behavior. Recent market data indicates consistent network usage within the decentralized asset management protocol ecosystem.
Outlook remains neutral with steady protocol adoption offset by limited market visibility. Key opportunities include growing DeFi ecosystem integration, while risks center on regulatory uncertainty and typical crypto volatility. Investors should monitor on-chain metrics for protocol growth signals.
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
A crypto asset founded by Gavin Wood (a co-founder of Ethereum) alongside co-founders Peter Czaban and Robert Habermeier in 2016. It was finally launched in 2020 with the goal of incentivizing the global network of computers to use blockchain for its operation which users can launch and operate their own blockchains system.
Read more on DOT →Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →